Iron deficiency anemia in reproductive-aged women: options for treatment and prevention

DOI: https://doi.org/10.29296/25877305-2023-02-10
Issue: 
2
Year: 
2023

Professor E. Bolotova, MD; V. Krutova, MD; A. Dudnikova, Candidate of Medical Sciences; V. Golubtsov, MD; N. Prosolupova; E. Dudnikova
Kuban State Medical University, Ministry of Health of Russia, Krasnodar

Objective. To assess the frequency of iron deficiency states among reproductive-aged women and to consider the features of their prevention. Subjects and methods. The investigation enrolled 2401 reproductive-aged patients who came first to the Clinic of the Kuban State Medical University in 2019. The patients’ mean age was 36.71±6.32 years; the follow-up period was 36 months. Results. Iron deficiency and iron deficiency anemia (IDA) were detected in 518 (21.6%) and 591 (15.9%) patients, respectively. At the same time, IDA was mild, moderate, and severe in 383 (15.9%); 202 (8.2%), and 6 (0.5%) patients, respectively. New-onset anemia was recorded in 70.3% of patients. A re-examination was carried out after 36 months, which involved 1917 patients (79.8% of the baseline patients). A total of 156 (8.1%) patients were diagnosed with mild and moderate (in 149 (7.7%) and 7 (0.3%) patients, respectively; latent iron deficiency was identified in 518 (21.6%) patients. At the same time, IDA was undetected in the patients who had followed the recommendations for prophylactic iron supplementation after reaching the target levels of serum hemoglobin and ferritin. Conclusion. An integrated approach that includes the informing of a patient about iron deficiency consequences, etiotropic and pathogenetic treatment, preventive drug use recommendations, and dynamic monitoring, assist in overcoming iron deficiency in reproductive-aged women.
Keywords: 
reproductive age
iron deficiency states
latent iron deficiency
prevention of iron deficiency

References: 
  1. Resolution WHA 65.6. Comprehensive implementation plan on maternal, infant and young child nutrition. Sixty-fifth World Health Assembly (Geneva, 21–26 May 2012). Resolutions and decisions, annexes. Geneva: WHO, 2012; p. 12–3.
  2. WHO. The global prevalence of anaemia in 2011 Geneva: WHO, 2015 43 p. Available at: https://www.who.int/nutrition/publications/micronutrients/global_prevalence_anaemia_2011/en/
  3. Tandu-Umba B., Mbangama A.M. Association of maternal anemia with other risk factors in occurrence of Great obstetrical syndromes at university clinics, Kinshasa, DR Congo. BMC Pregnancy Childbirth. 2015; 15: 183. DOI: 10.1186/s12884-015-0623-z
  4. Письмо Минздрава России от 04.09.15 г. №15-4/10/2-5079. Кровесберегающие технологии у гинекологических больных Клинические рекомендации (протокол лечения) [Pis'mo Minzdrava Rossii ot 04.09.15 g. №15-4/10/2-5079. Krovesberegayushchie tekhnologii u ginekologicheskikh bol'nykh Klinicheskie rekomendatsii (protokol lecheniya) (in Russ.)]. URL: http://www.transfusion.ru/2015/11-24-1.pdf
  5. Krutova V.A., Dudnikova A.V. Frequency and features of anemia in women of reproductive age. Gazzetta Medica Italiana Archivio per le Scienze Mediche. 2020; 179 (4): 270–5. DOI: 10.23736/S0393-3660.19.04095-6
  6. Железодефицитная анемия. Клинические рекомендации. Минздрав России, 2021 [Zhelezodefitsitnaya anemiya. Klinicheskie rekomendatsii. Minzdrav Rossii, 2021 (in Russ.)]. URL: https://cr.minzdrav.gov.ru/recomend/669_1?ysclid=l9mc2zl8gg960591894
  7. Branca F., Mahy L., Mustafa T.S. The lack of progress in reducing anaemia among women: the inconvenient truth. Bull World Health Organ. 2014; 92 (suppl. 4): 231. DOI: 10.2471/BLT.14.137810
  8. Stevens G.A., Finucane M.M., De-Regil L.M. et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013; 1 (suppl. 1): e16-25. DOI: 10.1016/S2214-109X(13)70001-9
  9. Milman N., Taylor C.L., Merkel J. et al. Iron status in pregnant women and women of reproductive age in Europe. Am J Clin Nutr. 2017; 106 (Suppl 6): 1655S-1662S. DOI: 10.3945/ajcn.117.156000
  10. Breymann C., Auerbach M. Iron deficiency in gynecology and obstetrics: clinical implications and management. Hematology Am Soc Hematol Educ Program. 2017; 1: 152–9. DOI: 10.1182/asheducation-2017.1.152
  11. Bernardi L.A., Ghant M.S., Andrade C. et al. The association between subjective assessment of menstrual bleeding and measures of iron deficiency anemia in premenopausal African-American women: a cross-sectional study. BMC Womens Health. 2016; 16 (suppl. 1): 50. DOI: 10.1186/s12905-016-0329-z
  12. Verstraelen H., Delanghe J., Roelens K. et al. Subclinical iron deficiency is a strong predictor of bacterial vaginosis in early pregnancy. BMC Infect Dis. 2005; 5: 55. DOI: 10.1186/1471-2334-5-55
  13. Petrova M.I., Lievens E., Malik S. et al. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol. 2015; 6: 81. DOI: 10.3389/fphys.2015.0008
  14. Назаренко Т.А., Мишиева Н.Г. Бесплодие и возраст: пути решения проблемы. М.: МЕДпресс-информ, 2014; 216 с. [Nazarenko T.A., Mishieva N.G. Besplodie i vozrast: puti resheniya problemy. M.: MEDpress-inform, 2014; 216 р. (in Russ.)].
  15. Aratani Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018; 15: 47–52. DOI: 10.1016/j.abb.2018.01.004
  16. Daru J., Colman K., Stanworth S.J. et al. Serum ferritin as an indicator of iron status: what do we need to know? Am J Clin Nutr. 2017; 106 (Suppl 6): 1634S-1639S. DOI: 10.3945/ajcn.117.155960
  17. Daniilidis A., Panteleris N., Vlachaki E. et al. Safety and efficacy of intravenous iron administration for uterine bleeding or postpartum anaemia: a narrative review. Obstet Gynaecol. 2018; 38 (Suppl 4): 443–7. DOI: 10.1080/01443615.2017.1363170
  18. Houston B.L., Hurrie D., Graham J. et al. Efficacy of iron supplementation on fatigue and physical capacity in non-anaemic iron-deficient adults: a systematic review of randomised controlled trials. BMJ Open. 2018; 8: e019240. DOI: 10.1136/bmjopen-2017-019240Greig A.J., Patterson A.J., Collins C.E. et al.. Iron deficiency, cognition, mental health and fatigue in women of childbearing age: a systematic review. J Nutr Sci. 2013; 2: e14. DOI: 10.1017/jns.2013.7
  19. Milman N., Jønsson L., Dyre P. et al. Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial. J Perinat Med. 2014; 42 (2): 197–206. DOI: 10.1515/jpm-2013-0153